ImageneBio Inc expected to post a loss of 89 cents a share - Earnings Preview

ImageneBio

20/07/2026 21:31

ImageneBio Inc IMA.OQ IMA.O is expected to  show no change in quarterly revenue when it reports  results on July 22 (estimated) for the period ending June 30 2026

​LSEG's mean analyst estimate for ImageneBio Inc is for a loss of 89 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for ImageneBio Inc is $13.00, about 141.6% above its last closing price of $5.38
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.71
-0.70
-0.95
Missed
-35
Dec. 31 2026
-1.45
-1.45
-1.42
Beat
1.8
Sep. 30 2025
-1.27
-1.28
-2.91
Missed
-127.3​
Jun. 30 2025
-1.68
-1.68
-0.72
Beat
57.1
​​Mar. 31 2025
-2.60
-2.52
-2.16
Beat
14.3
Dec. 31 2024
-2.26
-2.28
-2.28
Met
0​
Sep. 30 2024
-3.05
-3.20
-2.52
Beat
21.3
Jun. 30 2024
-3.92
-4.17
-3.36
Beat
19.4
This summary was machine generated July 20 at 20:31 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)